David Valenti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Valenti has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- David Roberge
Centre hospitalier de l’Université de Montréal (CHUM)
1 shared publication - Hooman Hennessey
Department of Oncology, Division of Radiation Oncology, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada
1 shared publication - Jeet Minocha
Department of Radiology, University of Illinois Hospital & Health Sciences System, 1740 West Taylor Street, Suite 2483, Chicago, IL, 60612, USA.
1 shared publication M A de Gregorio
1 shared publicationM J Lee
1 shared publication- Michael J. Lee
DEPARTMENT OF RADIOLOGY, BEAUMONT HOSPITAL, DUBLIN, IRELAND; ROYAL COLLEGE OF SURGEONS IN IRELAND, DUBLIN, IRELAND
1 shared publication
Latest Publications
- 1 May 2016
- Published by Georg Thieme Verlag KG in Interventionelle Radiologie Scan
- Vol. 04 (02) , 133-134
CIRSE-Datenerfassung ergab hohen Anteil wieder entfernter optionaler Cava-Filter
Über verschiedene entfernbare Cava-Filtertypen hinweg ergab die Erfassung in der CIRSE Registrierungsdatenbank mit 92 % einen hohen Anteil wieder entfernter Filter, bei niedrigen Majorkomplikationsraten von 0,03 % und Minorkomplikationsraten von 2 %. Allerdings bleibt unbekannt ob alle implantierten Filter in die Datenbank eingegeben wurden und wie viele Filter eingesetzt wurden ohne die Absicht, sie wieder zu entfernen.
- 1 May 2016
- Published by Georg Thieme Verlag KG in Interventionelle Radiologie Scan
- Vol. 04 (02) , 133-134
CIRSE-Datenerfassung ergab hohen Anteil wieder entfernter optionaler Cava-Filter
Über verschiedene entfernbare Cava-Filtertypen hinweg ergab die Erfassung in der CIRSE Registrierungsdatenbank mit 92 % einen hohen Anteil wieder entfernter Filter, bei niedrigen Majorkomplikationsraten von 0,03 % und Minorkomplikationsraten von 2 %. Allerdings bleibt unbekannt ob alle implantierten Filter in die Datenbank eingegeben wurden und wie viele Filter eingesetzt wurden ohne die Absicht, sie wieder zu entfernen.
- 2 May 2015
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (6) , 1502-1507
The CIRSE Retrievable IVC Filter Registry: Retrieval Success Rates in Practice
CIRSE established a registry of retrievable filter use with the primary aim of determining the success of IVC Filter retrieval and associated complications. Secondary endpoints included filter indications, imaging strategies before retrieval, filter dwell times, and anticoagulation status. A web-based electronic registry was hosted between 01/12/2010 and 30/06/2012. Data entry occurred at the date of IVC filter retrieval and included items such as filter type, indication for filter insertion, access route, dwell time, retrieval success, complications, reasons for failed retrieval, and anticoagulation status. 671 filter retrievals were entered (male:female 333:295, mean age 55, median 57). Retrieval data were not entered in 43/671 leaving 628 patients for analysis. The 4 commonest retrievable filters used were the Celect in 182 patients, the OPTEASE in 161, ALN in 120, and Gunther Tulip in 98. Filters were inserted for absolute indications 40 %, relative indications in 31 %, and prophylactic in 24 %, with 5 % missing. Mean filter dwell time was 90 days. Filters were successfully retrieved in 576/628 patients (92 %). The mean dwell time for successful retrievals was 85 days versus 145 days for unsuccessful retrievals (p = 0.001). Major complications occurred in 2 patients (0.03 %). In summary, the CIRSE retrievable filter registry demonstrates a retrieval rate of 92 % across a range of filter types, with a low major complication rate, reflecting current practice. There is an increase in trend of retrievable filter use for relative and prophylactic indications.
- 2 May 2015
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (6) , 1502-1507
The CIRSE Retrievable IVC Filter Registry: Retrieval Success Rates in Practice
CIRSE established a registry of retrievable filter use with the primary aim of determining the success of IVC Filter retrieval and associated complications. Secondary endpoints included filter indications, imaging strategies before retrieval, filter dwell times, and anticoagulation status. A web-based electronic registry was hosted between 01/12/2010 and 30/06/2012. Data entry occurred at the date of IVC filter retrieval and included items such as filter type, indication for filter insertion, access route, dwell time, retrieval success, complications, reasons for failed retrieval, and anticoagulation status. 671 filter retrievals were entered (male:female 333:295, mean age 55, median 57). Retrieval data were not entered in 43/671 leaving 628 patients for analysis. The 4 commonest retrievable filters used were the Celect in 182 patients, the OPTEASE in 161, ALN in 120, and Gunther Tulip in 98. Filters were inserted for absolute indications 40 %, relative indications in 31 %, and prophylactic in 24 %, with 5 % missing. Mean filter dwell time was 90 days. Filters were successfully retrieved in 576/628 patients (92 %). The mean dwell time for successful retrievals was 85 days versus 145 days for unsuccessful retrievals (p = 0.001). Major complications occurred in 2 patients (0.03 %). In summary, the CIRSE retrievable filter registry demonstrates a retrieval rate of 92 % across a range of filter types, with a low major complication rate, reflecting current practice. There is an increase in trend of retrievable filter use for relative and prophylactic indications.
- Open Access
- 20 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 140
Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
Introduction: In liver stereotactic body radiotherapy, reduction of normal tissue irradiation requires daily image guidance. This is typically accomplished by imaging a surrogate to the tumor. The surrogate is often an implanted metal fiducial marker. There are few reports addressing the specific risks of hepatic fiducial marker implantation. These risks are assumed to be similar to percutaneous liver biopsies which are associated with a 1-4% complication rate - almost always pain or bleeding. To the best of our knowledge, we present the first case of such a fiducial marker migrating to the heart. Case presentation: An 81-year-old Caucasian man (5 years post-gastrectomy for a gastric adenocarcinoma) was referred post-second line palliative chemotherapy for radiotherapy of an isolated liver metastasis. It was decided to proceed with treatment and platinum fiducials were chosen for radiation targeting. Under local anesthesia, three Nester embolization coils (Cook Medical Inc., Bloomington, IN, USA) were implanted under computed tomography guidance. Before the placement of each coil, the location of the tip of the delivery needle was confirmed by computed tomography imaging. During the procedure, the third coil unexpectedly migrated through the hepatic vein to the inferior vena cava and lodged at the junction of the vena cava and the right atrium. The patient remained asymptomatic. He was immediately referred to angiography for extraction of the coil. Using fluoroscopic guidance, an EN Snare Retrieval System (Hatch Medical L.L.C., Snellville, GA, USA) was introduced through a jugular catheter; it successfully grasped the coil and the coil was removed. The patient was kept overnight for observation and no immediate or delayed complications were encountered due to the migration or retrieval of the coil. He subsequently went on to be treated using the remaining fiducials. Conclusion: Implanted fiducial markers are increasingly used for stereotactic radiotherapy. There is sparse literature on the risks of such procedures. Although uncommon, the risk of migration does exist and therefore physicians (surgeons, oncologists and radiologists) and patients should be aware of this possibility.
- 20 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 140
Open AccessCardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
Introduction: In liver stereotactic body radiotherapy, reduction of normal tissue irradiation requires daily image guidance. This is typically accomplished by imaging a surrogate to the tumor. The surrogate is often an implanted metal fiducial marker. There are few reports addressing the specific risks of hepatic fiducial marker implantation. These risks are assumed to be similar to percutaneous liver biopsies which are associated with a 1-4% complication rate - almost always pain or bleeding. To the best of our knowledge, we present the first case of such a fiducial marker migrating to the heart. Case presentation: An 81-year-old Caucasian man (5 years post-gastrectomy for a gastric adenocarcinoma) was referred post-second line palliative chemotherapy for radiotherapy of an isolated liver metastasis. It was decided to proceed with treatment and platinum fiducials were chosen for radiation targeting. Under local anesthesia, three Nester embolization coils (Cook Medical Inc., Bloomington, IN, USA) were implanted under computed tomography guidance. Before the placement of each coil, the location of the tip of the delivery needle was confirmed by computed tomography imaging. During the procedure, the third coil unexpectedly migrated through the hepatic vein to the inferior vena cava and lodged at the junction of the vena cava and the right atrium. The patient remained asymptomatic. He was immediately referred to angiography for extraction of the coil. Using fluoroscopic guidance, an EN Snare Retrieval System (Hatch Medical L.L.C., Snellville, GA, USA) was introduced through a jugular catheter; it successfully grasped the coil and the coil was removed. The patient was kept overnight for observation and no immediate or delayed complications were encountered due to the migration or retrieval of the coil. He subsequently went on to be treated using the remaining fiducials. Conclusion: Implanted fiducial markers are increasingly used for stereotactic radiotherapy. There is sparse literature on the risks of such procedures. Although uncommon, the risk of migration does exist and therefore physicians (surgeons, oncologists and radiologists) and patients should be aware of this possibility.